Opportunity Information: Apply for RFA MH 21 186
Systems-Level Risk Detection and Interventions to Reduce Suicide, Ideation, and Behaviors in Black Children and Adolescents (R34 Clinical Trial Optional) is a National Institutes of Health (NIH) funding opportunity (RFA-MH-21-186) that supports early-stage, community-grounded pilot studies focused on preventing suicide among Black children and adolescents. The central idea is to fund projects that go beyond individual-level counseling or screening alone and instead design and test multi-level, systems-oriented approaches. These approaches are expected to either improve how suicide risk is detected and predicted within real-world settings, strengthen how Black youth at risk are identified and connected to appropriate services, or do both. The emphasis is on interventions that operate within and across the systems that young people actually encounter, such as schools, primary care, emergency departments, community mental health programs, child welfare, juvenile justice, faith-based organizations, and other community service networks.
This is an R34 mechanism, meaning it is aimed at developing and running pilot work that can demonstrate whether a new or adapted systems-level intervention is feasible and promising enough to justify a later, larger study. Applicants are expected to generate practical, decision-ready evidence about whether the approach works in the field: can it be implemented as intended, will youth and families use it, will providers and organizations adopt it, is it safe, and does it show early signals that it improves identification of risk and timely linkage to effective care and support. The FOA is listed as “Clinical Trial Optional,” which means projects may include a clinical trial component if appropriate, but a trial is not strictly required as long as the study still rigorously pilots the intervention and evaluates key outcomes relevant to suicide prevention and service connection.
A defining requirement is meaningful stakeholder involvement through community or stakeholder advisory boards. These advisory structures are not treated as symbolic add-ons; they are meant to shape the intervention itself, including how risk is identified, how referral pathways work, what services are offered or coordinated, how communication and follow-up occur, and how the program fits local context. Advisory boards are expected to include members of the communities served and may include youth, caregivers, community leaders, providers, school staff, health system representatives, and other local partners. The intent is to ensure the intervention is culturally responsive, realistic to implement, and aligned with community priorities, while also addressing barriers that disproportionately affect Black youth, such as access gaps, mistrust, stigma, and system fragmentation.
The opportunity also references a companion R01 program, which is positioned as the next step for projects that are ready to move from pilot testing to larger-scale efficacy or effectiveness research. In that larger stage, the focus expands to more definitive evaluation of outcomes, but for the R34 the goal is to produce the preliminary data needed to credibly compete for that subsequent level of funding. In practical terms, the R34 is meant to help teams refine the intervention and implementation strategy, demonstrate acceptability and safety, and establish the core procedures and partnerships necessary for a more rigorous, powered study later.
Eligibility is broad and includes many types of U.S.-based organizations that can realistically build cross-system partnerships around youth suicide prevention. Eligible applicants include state, county, city, township, and special district governments; independent school districts; public housing authorities; federally recognized Native American tribal governments and other tribal organizations; public and private institutions of higher education; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses) as well as small businesses; and other entities. The FOA explicitly highlights additional eligible applicants such as faith-based or community-based organizations, Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), along with U.S. territories or possessions. At the same time, foreign institutions are not eligible to apply, non-U.S. components of U.S. organizations are not eligible, and foreign components (as NIH defines them) are not allowed, reinforcing that the funded work must be carried out within eligible domestic contexts.
Administratively, this is a discretionary grant in the health funding category (CFDA 93.242) administered under NIH. The original closing date listed is June 29, 2021, and the award ceiling shown is $225,000. Overall, the opportunity is designed for teams that can bring together community partners and service systems to build practical, scalable ways to detect suicide risk earlier and create stronger, more reliable pathways that connect Black youth in crisis or at elevated risk to timely, appropriate, and effective supports.Apply for RFA MH 21 186
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Systems-Level Risk Detection and Interventions to Reduce Suicide, Ideation, and Behaviors in Black Children and Adolescents (R34 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242.
- This funding opportunity was created on 2021-04-16.
- Applicants must submit their applications by 2021-06-29. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $225,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Request for Information on Integrating Electric Vehicles onto the Electric Grid
Previous opportunity: FY2021 North America Marine Debris Prevention and Removal
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA MH 21 186
Applicants also applied for:
Applicants who have applied for this opportunity (RFA MH 21 186) also looked into and applied for these:
| Funding Opportunity |
|---|
| Centers for HIV Structural Biology (U54 Clinical Trial Not Allowed) Apply for RFA AI 21 030 Funding Number: RFA AI 21 030 Agency: National Institutes of Health Category: Health Funding Amount: $3,500,000 |
| NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed) Apply for PAR 21 234 Funding Number: PAR 21 234 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Systems Approach to Understand Mechanisms of Heterogeneous Response to Influenza (R01 Clinical Trial Not Allowed) Apply for RFA AI 21 017 Funding Number: RFA AI 21 017 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Resource Center for the Support for Research Excellence (SuRE) Program (U24 - Clinical Trial Not Allowed) Apply for PAR 21 227 Funding Number: PAR 21 227 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Translational Neural Devices (U44 Clinical Trial Optional) Apply for RFA NS 21 022 Funding Number: RFA NS 21 022 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Translational Neural Devices (UG3/UH3 - Clinical Trial Optional) Apply for RFA NS 21 021 Funding Number: RFA NS 21 021 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Addressing Social Determinants of Health to Eliminate Oral Health Disparities (UG3/UH3 Clinical Trials Optional) Apply for RFA DE 22 002 Funding Number: RFA DE 22 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R43/R44 Clinical Trial Not Allowed) Apply for PAR 21 225 Funding Number: PAR 21 225 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R41/R42 Clinical Trial Not Allowed) Apply for PAR 21 226 Funding Number: PAR 21 226 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Development and Renovation of Research Space for HIV/AIDS Research at Institutions Serving Underrepresented Populations or Located in Institutional Development Award (IDeA)-eligible States (C06 Clinical Trial Not Allowed) Apply for PAR 21 238 Funding Number: PAR 21 238 Agency: National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| NeuroNEXT Clinical Trials (U01 Clinical Trial Optional) Apply for PAR 21 223 Funding Number: PAR 21 223 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional) Apply for PAR 21 224 Funding Number: PAR 21 224 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Guinea Local Health System Strengthening Activity (LHSSA) Apply for RFI 675 21 LHSSA 02 Funding Number: RFI 675 21 LHSSA 02 Agency: Guinea USAID-Conakry Category: Health Funding Amount: Case Dependent |
| Consortium for Innovative HIV/AIDS Vaccine and Cure Research (UM1 Clinical Trial Not Allowed) Apply for RFA AI 21 039 Funding Number: RFA AI 21 039 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIMH Research Education Mentoring Program for HIV/AIDS Researchers (R25 Clinical Trial Not Allowed) Apply for PAR 21 228 Funding Number: PAR 21 228 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NINDS Exploratory Clinical Trials (U01 - Clinical Trial Required) Apply for PAR 21 236 Funding Number: PAR 21 236 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIMH Exploratory/Developmental Research Grant (R21 Clinical Trial Not Allowed) Apply for PA 21 235 Funding Number: PA 21 235 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Optional) Apply for PA 21 219 Funding Number: PA 21 219 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Emerging Science and Technology in Transplantation (U01 Clinical Trial Not Allowed) Apply for RFA AI 21 016 Funding Number: RFA AI 21 016 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| T32 Training Program for Institutions That Promote Diversity (T32 Clinical Trial Not Allowed) Apply for RFA HL 22 001 Funding Number: RFA HL 22 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA MH 21 186", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
